SE433170B - Forfarande for framstellning av en farmakologiskt godtagbar komposition omfattande hygroskopisk poly-/(metyl-(3-trimetylammoniopropyl)iminio)trimetylen-diklorid/ - Google Patents
Forfarande for framstellning av en farmakologiskt godtagbar komposition omfattande hygroskopisk poly-/(metyl-(3-trimetylammoniopropyl)iminio)trimetylen-diklorid/Info
- Publication number
- SE433170B SE433170B SE7801242A SE7801242A SE433170B SE 433170 B SE433170 B SE 433170B SE 7801242 A SE7801242 A SE 7801242A SE 7801242 A SE7801242 A SE 7801242A SE 433170 B SE433170 B SE 433170B
- Authority
- SE
- Sweden
- Prior art keywords
- poly
- methyl
- trimethylammoniopropyl
- dichloride
- suspension
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 36
- -1 IMINIO Chemical class 0.000 title claims description 30
- 238000000034 method Methods 0.000 title claims description 11
- 230000000144 pharmacologic effect Effects 0.000 title 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 57
- 239000000377 silicon dioxide Substances 0.000 claims description 28
- 239000002156 adsorbate Substances 0.000 claims description 20
- 239000000725 suspension Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- YHRUOJUYPBUZOS-UHFFFAOYSA-N 1,3-dichloropropane Chemical compound ClCCCCl YHRUOJUYPBUZOS-UHFFFAOYSA-N 0.000 claims description 5
- 230000001464 adherent effect Effects 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 230000002035 prolonged effect Effects 0.000 claims description 3
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 claims description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000000843 powder Substances 0.000 description 4
- 239000002775 capsule Substances 0.000 description 3
- 238000007580 dry-mixing Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229920001800 Shellac Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000004208 shellac Substances 0.000 description 2
- 229940113147 shellac Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- VXEGSRKPIUDPQT-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 VXEGSRKPIUDPQT-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004965 Silica aerogel Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 229920000080 bile acid sequestrant Polymers 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003312 cholesterol blood level Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013766 direct food additive Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000005498 phthalate group Chemical class 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000005049 silicon tetrachloride Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76949177A | 1977-02-17 | 1977-02-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7801242L SE7801242L (sv) | 1978-08-18 |
| SE433170B true SE433170B (sv) | 1984-05-14 |
Family
ID=25085598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7801242A SE433170B (sv) | 1977-02-17 | 1978-02-02 | Forfarande for framstellning av en farmakologiskt godtagbar komposition omfattande hygroskopisk poly-/(metyl-(3-trimetylammoniopropyl)iminio)trimetylen-diklorid/ |
Country Status (26)
| Country | Link |
|---|---|
| JP (1) | JPS53102958A (de) |
| AT (1) | AT363173B (de) |
| AU (1) | AU518127B2 (de) |
| BE (1) | BE863930A (de) |
| CA (1) | CA1109395A (de) |
| CH (1) | CH636012A5 (de) |
| DE (1) | DE2806707A1 (de) |
| DK (1) | DK46578A (de) |
| ES (1) | ES466892A1 (de) |
| FI (1) | FI67483C (de) |
| FR (1) | FR2381079A1 (de) |
| GB (1) | GB1567294A (de) |
| GR (1) | GR66100B (de) |
| HU (1) | HU177685B (de) |
| IE (1) | IE46408B1 (de) |
| IL (1) | IL53978A (de) |
| IT (1) | IT7848013A0 (de) |
| LU (1) | LU79071A1 (de) |
| NL (1) | NL7801240A (de) |
| NO (1) | NO148838C (de) |
| NZ (1) | NZ186399A (de) |
| PH (1) | PH15263A (de) |
| PL (1) | PL122299B1 (de) |
| PT (1) | PT67663B (de) |
| SE (1) | SE433170B (de) |
| ZA (1) | ZA78913B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6129910A (en) * | 1993-06-02 | 2000-10-10 | Geltex Pharmaceuticals, Inc. | Water-insoluble noncrosslinked bile acid sequestrants |
| US5929184A (en) * | 1993-06-02 | 1999-07-27 | Geltex Pharmaceuticals, Inc. | Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants |
| US5624963A (en) * | 1993-06-02 | 1997-04-29 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
| US5607669A (en) * | 1994-06-10 | 1997-03-04 | Geltex Pharmaceuticals, Inc. | Amine polymer sequestrant and method of cholesterol depletion |
| US5900475A (en) * | 1994-06-10 | 1999-05-04 | Geltex Pharmaceuticals, Inc. | Hydrophobic sequestrant for cholesterol depletion |
| US5703188A (en) * | 1993-06-02 | 1997-12-30 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
| US5618530A (en) * | 1994-06-10 | 1997-04-08 | Geltex Pharmaceuticals, Inc. | Hydrophobic amine polymer sequestrant and method of cholesterol depletion |
| TW474813B (en) | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
| US5709880A (en) * | 1995-07-10 | 1998-01-20 | Buckman Laboratories International, Inc. | Method of making tabletized ionene polymers |
| EP0778027A3 (de) | 1995-12-04 | 1998-04-01 | Helmut Univ.-Prof. Dr. Wachter | Verwendung von Kieselerde zur Herstellung von Arzneimitteln |
| JP4010585B2 (ja) * | 1996-10-15 | 2007-11-21 | 久光製薬株式会社 | 陰イオン交換樹脂を含有する錠剤 |
| US6203785B1 (en) | 1996-12-30 | 2001-03-20 | Geltex Pharmaceuticals, Inc. | Poly(diallylamine)-based bile acid sequestrants |
| US6423754B1 (en) | 1997-06-18 | 2002-07-23 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with polyallylamine polymers |
| US6726905B1 (en) | 1997-11-05 | 2004-04-27 | Genzyme Corporation | Poly (diallylamines)-based phosphate binders |
| CN116925354B (zh) * | 2023-07-20 | 2025-09-23 | 黑龙江省科学院石油化学研究院 | 一种高强度的聚酰亚胺气凝胶褶皱纸及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR206115A1 (es) * | 1973-06-11 | 1976-06-30 | Merck & Co Inc | Procedimiento para preparar un polimero lineal no ramificado y no reticulado |
| US4027009A (en) * | 1973-06-11 | 1977-05-31 | Merck & Co., Inc. | Compositions and methods for depressing blood serum cholesterol |
-
1978
- 1978-01-30 FI FI780296A patent/FI67483C/fi not_active IP Right Cessation
- 1978-02-01 DK DK46578A patent/DK46578A/da not_active Application Discontinuation
- 1978-02-02 NO NO780367A patent/NO148838C/no unknown
- 1978-02-02 SE SE7801242A patent/SE433170B/sv unknown
- 1978-02-02 NL NL7801240A patent/NL7801240A/xx not_active Application Discontinuation
- 1978-02-06 IL IL53978A patent/IL53978A/xx unknown
- 1978-02-06 GR GR55356A patent/GR66100B/el unknown
- 1978-02-06 PH PH20753A patent/PH15263A/en unknown
- 1978-02-07 NZ NZ186399A patent/NZ186399A/xx unknown
- 1978-02-08 AU AU33099/78A patent/AU518127B2/en not_active Expired
- 1978-02-08 CA CA296,622A patent/CA1109395A/en not_active Expired
- 1978-02-08 AT AT0087978A patent/AT363173B/de not_active IP Right Cessation
- 1978-02-09 HU HU78ME2145A patent/HU177685B/hu unknown
- 1978-02-10 ES ES466892A patent/ES466892A1/es not_active Expired
- 1978-02-10 IT IT7848013A patent/IT7848013A0/it unknown
- 1978-02-14 BE BE185141A patent/BE863930A/xx not_active IP Right Cessation
- 1978-02-14 CH CH162578A patent/CH636012A5/de not_active IP Right Cessation
- 1978-02-15 LU LU79071A patent/LU79071A1/xx unknown
- 1978-02-15 FR FR7804268A patent/FR2381079A1/fr active Granted
- 1978-02-15 GB GB6014/78A patent/GB1567294A/en not_active Expired
- 1978-02-15 PL PL1978204642A patent/PL122299B1/pl unknown
- 1978-02-16 PT PT67663A patent/PT67663B/pt unknown
- 1978-02-16 DE DE19782806707 patent/DE2806707A1/de not_active Withdrawn
- 1978-02-16 ZA ZA00780913A patent/ZA78913B/xx unknown
- 1978-02-16 IE IE332/78A patent/IE46408B1/en unknown
- 1978-02-17 JP JP1666278A patent/JPS53102958A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE433170B (sv) | Forfarande for framstellning av en farmakologiskt godtagbar komposition omfattande hygroskopisk poly-/(metyl-(3-trimetylammoniopropyl)iminio)trimetylen-diklorid/ | |
| US2921883A (en) | Novel coating material for medicaments | |
| EP0991646B1 (de) | Ein itraconazol mit einer verbesserten löslichkeit, ein verfahren zu seiner herstellung und eine pharmazeutische zusammensetzung zur oralen verabreichung, die dieses enthält | |
| US7662799B2 (en) | Powder of amino acids and method for producing the same | |
| JPS63162627A (ja) | 徐放性医薬製剤 | |
| SE448819B (sv) | Pulver och suspension av mikrokapslad bakampicillin-syraadditionssalt | |
| US4258179A (en) | Coating agents for solid medicaments | |
| JPS58185578A (ja) | 新規結晶形の（＋）―カテキン１水和物，その製造方法及びそれを含有する固形製剤 | |
| JP2019502658A (ja) | ビタミン製剤 | |
| KR101269911B1 (ko) | 홍삼 오일을 부형제 오일로 함유하는 연질캡슐제 | |
| US4185088A (en) | Non-adhesive ionene quaternary polymer compositions useful as bile acid sequestrants | |
| KR20150048409A (ko) | 고체분산체 형태의 타달라필을 함유하는 구강 붕해 필름 및 이의 제조방법 | |
| JP2002511404A (ja) | コーティングされたデンプンカプセル、およびこれらの製造方法 | |
| KR101739695B1 (ko) | 용해성, 항인습성 및 유동성이 우수한 홍삼농축액 과립의 제조 방법 | |
| US5733551A (en) | Process for preparing spheroids of plant origin | |
| JPS61141862A (ja) | 可食性徐放性顆粒 | |
| CN107115325A (zh) | 一种琥珀酸呋罗曲坦胶囊及其制备方法 | |
| US2762746A (en) | Composition for combating malaria and process of making same | |
| HU186431B (en) | Process for preparing coated acetyl-salicilyc acid derivatives | |
| Eziuzo et al. | Formulation and Evaluation of Sustained Release Tablet of Metformin by Ionic Gelation Technique using Sida acuta Gum as Release Retardant | |
| US3398226A (en) | Complex of thiamine and a styrenemaleic anhydride copolymer | |
| CN106692980A (zh) | 水飞蓟宾口服固体制剂及其制备方法 | |
| CN106913543A (zh) | 一种达比加群酯片剂及其制备方法 | |
| JP2516542B2 (ja) | 乳酸菌含有瀉下薬組成物 | |
| CN120154737A (zh) | 一种脂溶性维生素制剂中间体及其制备方法 |